Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
91.94
-1.76 (-1.87%)
Jan 17, 2025, 4:00 PM EST - Market closed
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $4.46 billion as of January 21, 2025. Its market cap has increased by 23.74% in one year.
Market Cap
4.46B
Enterprise Value
4.32B
1-Year Change
23.74%
Ranking
Category
Stock Price
$91.94
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $4.46B, an increase of 2,776.30%. That is a compound annual growth rate of 44.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jan 17, 2025 | 4.46B | 8.66% |
Dec 31, 2024 | 4.10B | 8.87% |
Dec 29, 2023 | 3.77B | 12.44% |
Dec 30, 2022 | 3.35B | 135.22% |
Dec 31, 2021 | 1.42B | -53.19% |
Dec 31, 2020 | 3.04B | -14.70% |
Dec 31, 2019 | 3.57B | 4,141.14% |
Dec 31, 2018 | 84.10M | -36.58% |
Dec 29, 2017 | 132.60M | 2.55% |
Dec 30, 2016 | 129.30M | -21.30% |
Dec 31, 2015 | 164.30M | 6.07% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 653.46B |
UnitedHealth Group | 469.12B |
Johnson & Johnson | 353.99B |
Novo Nordisk | 341.33B |
AbbVie | 303.17B |
Merck & Co. | 247.70B |
Thermo Fisher Scientific | 214.07B |
Intuitive Surgical | 211.09B |